Recent research regarding Alopecia

Eight genes responsible for enabling alopecia have been isolated recently in a study published by a group of physicians and investigators at the Columbia University Medical Center. One gene among the group of eight is thought to be the possible initiator of the disease.

With these specific genes isolated, an eventual cure for the disease is thought to be possible.

There are foundations and scientific studies dedicated to the scrutiny of the possible causes and triggers of the disease. If they wish, patients suffering the symptoms of Alopecia can register their details with special foundations dedicated to the study of all forms of Alopecia. These foundations collate data gathered from a broad range of people with the disease. They hope that a wide database of cases will assist scientists in developing a cure for the disease. Patients may be expected to donate blood or tissue samples in addition to detailed personal histories.

This compiled data can then be studied to produce a detailed profile of the mechanisms of the disease as well as the efficacy of certain medications.

The FDA has approved clinical trials of drugs used to treat other autoimmune diseases for use on patients with Alopecia. Medication designed to treat rheumatoid arthritis shows promise in inhibiting autoimmune responses like those found in cases of Alopecia. While it can take many years to develop medications suitable for use on a large scale, early trials appear promising. Researchers remain hopeful that isolating the genes responsible for triggering the disease, as well as developing medications designed specifically to suppress the the body’s autoimmune response will serve to alleviate or heal conditions caused by Alopecia.

Speak Your Mind